Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Teladoc HealthSTU:4LL +2.22%51 EV-to-FCF is 12.75 as of Aug. 02, 2026, which is 25% above its 10-year median of 10.22. GuruFocus rates STU:4LL with a GF Score™ of 51/100 and a GF Value™ of €47.55 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Teladoc Health ranks better than 62.07% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Teladoc Health's Enterprise Value is €1,285 Mil.
Teladoc Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was €101 Mil. Therefore, Teladoc Health's EV-to-FCF for today is 12.75.
The historical rank and industry rank for Teladoc Health's EV-to-FCF or its related term are showing as below:
STU:4LL'
s EV-to-FCF Range Over the Past 10 Years
Min: -590.07 Med: 10.22 Max: 3059.28
Current: 12.54
During the past 13 years, the highest EV-to-FCF of Teladoc Health was 3059.28. The lowest was -590.07. And the median was 10.22.
STU:4LL's EV-to-FCF is ranked better than 62.07% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.96
vs STU:4LL: 12.54
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Teladoc Health's PE Ratio (TTM) for today is calculated as:
Teladoc Health's share price for today is €5.81.
Teladoc Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-9.883.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Teladoc Health EV-to-FCF Related Terms
Teladoc Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Teladoc Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Teladoc Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teladoc Health EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Teladoc Health's EV-to-FCF falls into.
Teladoc Health's current Enterprise Value is €1,285 Mil.
Teladoc Health's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €101 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teladoc Health (STU:4LL) has a EV-to-FCF of 12.75 as of Aug. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Teladoc Health and its competitors. This is 25% above median its historical median of 10.22. According to the industry distribution chart, Teladoc Health ranks #154 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 37.9%.
Is Teladoc Health's EV-to-FCF too high?
Teladoc Health's current EV-to-FCF of 12.75 is 25% above median its 10-year median of 10.22. The Healthcare Providers & Services industry median EV-to-FCF is 17.96. Teladoc Health's value of 12.75 is 29% below this industry median. Based on the distribution chart, Teladoc Health ranks #154 out of 406 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Teladoc Health has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's EV-to-FCF compare to OMCL and OMDA?
According to the Healthcare Providers & Services industry distribution chart, Teladoc Health ranks #154 out of 406 companies for EV-to-FCF. This puts Teladoc Health in the upper half of its industry. The industry median EV-to-FCF is 17.96. Teladoc Health's value of 12.75 is 29% below this benchmark. While the company's 10-year median is 10.22 vs. the industry median of 17.96, Teladoc Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.96, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teladoc Health's current EV-to-FCF of 12.75 is 29% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Teladoc Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teladoc Health's current EV-to-FCF is 12.75, which is 25% above median its own 10-year median of 10.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (STU:4LL) is currently considered Possible Value Trap. The stock's GF Value™ is €47.55, compared to a current price of €5.81 — trading 87.8% below its estimated fair value. The current EV-to-FCF is 12.75, which is 25% above median its 10-year median of 10.22 and 29% below the Healthcare Providers & Services industry median of 17.96. Teladoc Health's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Teladoc Health (STU:4LL), the current EV-to-FCF is 12.75 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Teladoc Health (STU:4LL) Overvalued in 2026?
Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued.
The current stock price of €5.81 is trading 87.8% below its estimated GF Value™ of €47.55.
GuruFocus considers Teladoc Health to be Possible Value Trap.
Key valuation signals for STU:4LL:
EV-to-FCF: 12.75 (25% above median its 10-year median of 10.22)
GF Value™: €47.55 vs. price of €5.81 (87.8% below fair value)
Industry Position: 29% below the Healthcare Providers & Services median (#154 of 406)
No single metric tells the full story. See the STU:4LL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
51GF Score
Get the complete analysis for STU:4LL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:4LL has been successfully added to your 
